Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- A diet rich in omega-3 fatty acids may lower prostate cancer genetic risk
Researchers observe that, based on amouse model study, a diet rich in omega-3 polyunsaturated fatty acids found in certain fish or fish oil, nuts, seeds, and vegetable oils may help lower prostate cancer risk in individuals with a genetic predisposition to cancer.
- Green tea may halve risk of colon cancer
A study from China, published in Cancer Epidemiology, Biomarkers and Prevention, has reported beneficial associations between regular consumption of green tea and colorectal cancer risk.
- Green tea may halve risk of colon cancer
A study from China, published in Cancer Epidemiology, Biomarkers and Prevention, has reported beneficial associations between regular consumption of green tea and colorectal cancer risk.
- Green tea may halve risk of colon cancer
A study from China, published in Cancer Epidemiology, Biomarkers and Prevention, has reported beneficial associations between regular consumption of green tea and colorectal cancer risk.
- Cargill announces positive results of clinical study using Cosucra's prebiotic inulin
A double-blind, randomized, placebo-controlled study, published in the journal Nutrition Research, has found that after four weeks of consuming 2.5 grams of inulin twice daily, there was a 10-fold increase in counts of beneficial Bifidobacteria among healthy volunteers. According to a releasze issued by Cargill, which distributes the prebiotic inulin used in the study, those consuming inulin also experienced a noted decrease in activity of beta-glucuronidase, an enzyme that may play a role in increasing the amount of carcinogens in the colon.
- Cargill announces positive results of clinical study using Cosucra's prebiotic inulin
A double-blind, randomized, placebo-controlled study, published in the journal Nutrition Research, has found that after four weeks of consuming 2.5 grams of inulin twice daily, there was a 10-fold increase in counts of beneficial Bifidobacteria among healthy volunteers. According to a releasze issued by Cargill, which distributes the prebiotic inulin used in the study, those consuming inulin also experienced a noted decrease in activity of beta-glucuronidase, an enzyme that may play a role in increasing the amount of carcinogens in the colon.
- Cargill announces positive results of clinical study using Cosucra's prebiotic inulin
A double-blind, randomized, placebo-controlled study, published in the journal Nutrition Research, has found that after four weeks of consuming 2.5 grams of inulin twice daily, there was a 10-fold increase in counts of beneficial Bifidobacteria among healthy volunteers. According to a releasze issued by Cargill, which distributes the prebiotic inulin used in the study, those consuming inulin also experienced a noted decrease in activity of beta-glucuronidase, an enzyme that may play a role in increasing the amount of carcinogens in the colon.
- New Cell Research Confirms Wild Blueberry Antioxidant Power
New research published in the current issue of the Journal of Agricultural and Food Chemistry (55 (22), 8896-8907, 2007) shows that Wild Blueberries have the highest cellular antioxidant activity of selected fruits tested.
- New Cell Research Confirms Wild Blueberry Antioxidant Power
New research published in the current issue of the Journal of Agricultural and Food Chemistry (55 (22), 8896-8907, 2007) shows that Wild Blueberries have the highest cellular antioxidant activity of selected fruits tested.
- New Cell Research Confirms Wild Blueberry Antioxidant Power
New research published in the current issue of the Journal of Agricultural and Food Chemistry (55 (22), 8896-8907, 2007) shows that Wild Blueberries have the highest cellular antioxidant activity of selected fruits tested.
- New Cell Research Confirms Wild Blueberry Antioxidant Power
New research published in the current issue of the Journal of Agricultural and Food Chemistry (55 (22), 8896-8907, 2007) shows that Wild Blueberries have the highest cellular antioxidant activity of selected fruits tested.
- Cysteine-Rich Protein Prevents Weight Loss in Lung Cancer Patients: A Promising Intervention Study
Immunotec Inc. has announced the successful completion of a multi-center randomized, double-blind clinical trial on cancer-related weight loss (cachexia) in lung cancer patients, concluding that patients treated with IMN 1207, a research formulation of the undenatured whey protein Immunocal(R)/HMS 90(R), a dietary natural health supplement and precursor to glutathione, showed significant increases in body weight (Tozer et al. Antioxidants & Redox Signaling (2008) 10:395-402).
- Cysteine-Rich Protein Prevents Weight Loss in Lung Cancer Patients: A Promising Intervention Study
Immunotec Inc. has announced the successful completion of a multi-center randomized, double-blind clinical trial on cancer-related weight loss (cachexia) in lung cancer patients, concluding that patients treated with IMN 1207, a research formulation of the undenatured whey protein Immunocal(R)/HMS 90(R), a dietary natural health supplement and precursor to glutathione, showed significant increases in body weight (Tozer et al. Antioxidants & Redox Signaling (2008) 10:395-402).
- Cysteine-Rich Protein Prevents Weight Loss in Lung Cancer Patients: A Promising Intervention Study
Immunotec Inc. has announced the successful completion of a multi-center randomized, double-blind clinical trial on cancer-related weight loss (cachexia) in lung cancer patients, concluding that patients treated with IMN 1207, a research formulation of the undenatured whey protein Immunocal(R)/HMS 90(R), a dietary natural health supplement and precursor to glutathione, showed significant increases in body weight (Tozer et al. Antioxidants & Redox Signaling (2008) 10:395-402).
- Cysteine-Rich Protein Prevents Weight Loss in Lung Cancer Patients: A Promising Intervention Study
Immunotec Inc. has announced the successful completion of a multi-center randomized, double-blind clinical trial on cancer-related weight loss (cachexia) in lung cancer patients, concluding that patients treated with IMN 1207, a research formulation of the undenatured whey protein Immunocal(R)/HMS 90(R), a dietary natural health supplement and precursor to glutathione, showed significant increases in body weight (Tozer et al. Antioxidants & Redox Signaling (2008) 10:395-402).
- HMR Shown to Positively Influence Enterolactone’s Role In Controlling Prostate Cancer Cell Proliferation
The study, published in Molecular Nutrition & Food Research, entitled, “Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro,” examines the molecular mechanisms by which enterolactone may influence LNCaP proliferation.
- HMR Shown to Positively Influence Enterolactone’s Role In Controlling Prostate Cancer Cell Proliferation
The study, published in Molecular Nutrition & Food Research, entitled, “Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro,” examines the molecular mechanisms by which enterolactone may influence LNCaP proliferation.
- HMR Shown to Positively Influence Enterolactone’s Role In Controlling Prostate Cancer Cell Proliferation
The study, published in Molecular Nutrition & Food Research, entitled, “Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro,” examines the molecular mechanisms by which enterolactone may influence LNCaP proliferation.
- HMR Shown to Positively Influence Enterolactone’s Role In Controlling Prostate Cancer Cell Proliferation
The study, published in Molecular Nutrition & Food Research, entitled, “Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro,” examines the molecular mechanisms by which enterolactone may influence LNCaP proliferation.
- HMR Shown to Positively Influence Enterolactone’s Role In Controlling Prostate Cancer Cell Proliferation
The study, published in Molecular Nutrition & Food Research, entitled, “Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro,” examines the molecular mechanisms by which enterolactone may influence LNCaP proliferation.
- HMR Shown to Positively Influence Enterolactone’s Role In Controlling Prostate Cancer Cell Proliferation
The study, published in Molecular Nutrition & Food Research, entitled, “Enterolactone restricts the proliferation of the LNCaP human prostate cancer cell line in vitro,” examines the molecular mechanisms by which enterolactone may influence LNCaP proliferation.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Research Presented at the AHCC International Research Symposium Shows Potential Cancer Preventative Effects
The 16th International AHCC® (Active Hexose Correlated Compound) Symposium was held in Sapporo, Japan on July 26th and 27th, attended by over 300 medical doctors and researchers from around the world that presented and discussed research studies completed with AHCC. Researchers at Yale, in collaboration with researchers in Japan, have confirmed that AHCC significantly enhances the immune system in a manner that may prove significant for healthy immune function and as a cancer preventative for older Americans.
- Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients
Vitamin D deficiency was found to be prevalent in cancer patients regardless of nutritional status, according to the results of a recent study conducted at Cancer Treatment Centers of America. Based on these results, CTCA researchers determined that screening for vitamin D deficiency and aggressive vitamin D repletion should be considered for all people with cancer.
- Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients
Vitamin D deficiency was found to be prevalent in cancer patients regardless of nutritional status, according to the results of a recent study conducted at Cancer Treatment Centers of America. Based on these results, CTCA researchers determined that screening for vitamin D deficiency and aggressive vitamin D repletion should be considered for all people with cancer.
- Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients
Vitamin D deficiency was found to be prevalent in cancer patients regardless of nutritional status, according to the results of a recent study conducted at Cancer Treatment Centers of America. Based on these results, CTCA researchers determined that screening for vitamin D deficiency and aggressive vitamin D repletion should be considered for all people with cancer.
- Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients
Vitamin D deficiency was found to be prevalent in cancer patients regardless of nutritional status, according to the results of a recent study conducted at Cancer Treatment Centers of America. Based on these results, CTCA researchers determined that screening for vitamin D deficiency and aggressive vitamin D repletion should be considered for all people with cancer.
- Study Suggests Vitamin D Screening and Appropriate Supplementation Indicated for All Cancer Patients
Vitamin D deficiency was found to be prevalent in cancer patients regardless of nutritional status, according to the results of a recent study conducted at Cancer Treatment Centers of America. Based on these results, CTCA researchers determined that screening for vitamin D deficiency and aggressive vitamin D repletion should be considered for all people with cancer.
- Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
Body mass index should be taken into account when assessing a cancer patient's vitamin D status, according to researchers at Cancer Treatment Centers of America, who found that obese cancer patients had significantly lower levels of vitamin D compared to non-obese patients.
- Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
Body mass index should be taken into account when assessing a cancer patient's vitamin D status, according to researchers at Cancer Treatment Centers of America, who found that obese cancer patients had significantly lower levels of vitamin D compared to non-obese patients.
- Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
Body mass index should be taken into account when assessing a cancer patient's vitamin D status, according to researchers at Cancer Treatment Centers of America, who found that obese cancer patients had significantly lower levels of vitamin D compared to non-obese patients.
- Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
Body mass index should be taken into account when assessing a cancer patient's vitamin D status, according to researchers at Cancer Treatment Centers of America, who found that obese cancer patients had significantly lower levels of vitamin D compared to non-obese patients.
- Researchers Say More Aggressive Vitamin D Supplementation Needed in Obese Cancer Patients
Body mass index should be taken into account when assessing a cancer patient's vitamin D status, according to researchers at Cancer Treatment Centers of America, who found that obese cancer patients had significantly lower levels of vitamin D compared to non-obese patients.
- Positive pharmacological and clinical data for chemoprevention on bilberry extract
Pharmacological and clinical data for colorectal carcinoma chemoprevention on Indena’s standardized bilberry extract Mirtoselect® were presented by Professor Andreas Gescher from the University of Leicester (UK) at the 51st Annual Meeting of the Italian Cancer Society (SIC) in Sesto San Giovanni, Milano (November 23rd-24th, 2009) during the session of “Dietary Supplements and Nutraceuticals in the Management of Cancer”.
- Positive pharmacological and clinical data for chemoprevention on bilberry extract
Pharmacological and clinical data for colorectal carcinoma chemoprevention on Indena’s standardized bilberry extract Mirtoselect® were presented by Professor Andreas Gescher from the University of Leicester (UK) at the 51st Annual Meeting of the Italian Cancer Society (SIC) in Sesto San Giovanni, Milano (November 23rd-24th, 2009) during the session of “Dietary Supplements and Nutraceuticals in the Management of Cancer”.
- Positive pharmacological and clinical data for chemoprevention on bilberry extract
Pharmacological and clinical data for colorectal carcinoma chemoprevention on Indena’s standardized bilberry extract Mirtoselect® were presented by Professor Andreas Gescher from the University of Leicester (UK) at the 51st Annual Meeting of the Italian Cancer Society (SIC) in Sesto San Giovanni, Milano (November 23rd-24th, 2009) during the session of “Dietary Supplements and Nutraceuticals in the Management of Cancer”.
- Positive pharmacological and clinical data for chemoprevention on bilberry extract
Pharmacological and clinical data for colorectal carcinoma chemoprevention on Indena’s standardized bilberry extract Mirtoselect® were presented by Professor Andreas Gescher from the University of Leicester (UK) at the 51st Annual Meeting of the Italian Cancer Society (SIC) in Sesto San Giovanni, Milano (November 23rd-24th, 2009) during the session of “Dietary Supplements and Nutraceuticals in the Management of Cancer”.
- Positive pharmacological and clinical data for chemoprevention on bilberry extract
Pharmacological and clinical data for colorectal carcinoma chemoprevention on Indena’s standardized bilberry extract Mirtoselect® were presented by Professor Andreas Gescher from the University of Leicester (UK) at the 51st Annual Meeting of the Italian Cancer Society (SIC) in Sesto San Giovanni, Milano (November 23rd-24th, 2009) during the session of “Dietary Supplements and Nutraceuticals in the Management of Cancer”.
- Positive pharmacological and clinical data for chemoprevention on bilberry extract
Pharmacological and clinical data for colorectal carcinoma chemoprevention on Indena’s standardized bilberry extract Mirtoselect® were presented by Professor Andreas Gescher from the University of Leicester (UK) at the 51st Annual Meeting of the Italian Cancer Society (SIC) in Sesto San Giovanni, Milano (November 23rd-24th, 2009) during the session of “Dietary Supplements and Nutraceuticals in the Management of Cancer”.
- Positive pharmacological and clinical data for chemoprevention on bilberry extract
Pharmacological and clinical data for colorectal carcinoma chemoprevention on Indena’s standardized bilberry extract Mirtoselect® were presented by Professor Andreas Gescher from the University of Leicester (UK) at the 51st Annual Meeting of the Italian Cancer Society (SIC) in Sesto San Giovanni, Milano (November 23rd-24th, 2009) during the session of “Dietary Supplements and Nutraceuticals in the Management of Cancer”.
- Positive pharmacological and clinical data for chemoprevention on bilberry extract
Pharmacological and clinical data for colorectal carcinoma chemoprevention on Indena’s standardized bilberry extract Mirtoselect® were presented by Professor Andreas Gescher from the University of Leicester (UK) at the 51st Annual Meeting of the Italian Cancer Society (SIC) in Sesto San Giovanni, Milano (November 23rd-24th, 2009) during the session of “Dietary Supplements and Nutraceuticals in the Management of Cancer”.
- Positive pharmacological and clinical data for chemoprevention on bilberry extract
Pharmacological and clinical data for colorectal carcinoma chemoprevention on Indena’s standardized bilberry extract Mirtoselect® were presented by Professor Andreas Gescher from the University of Leicester (UK) at the 51st Annual Meeting of the Italian Cancer Society (SIC) in Sesto San Giovanni, Milano (November 23rd-24th, 2009) during the session of “Dietary Supplements and Nutraceuticals in the Management of Cancer”.
- Positive pharmacological and clinical data for chemoprevention on bilberry extract
Pharmacological and clinical data for colorectal carcinoma chemoprevention on Indena’s standardized bilberry extract Mirtoselect® were presented by Professor Andreas Gescher from the University of Leicester (UK) at the 51st Annual Meeting of the Italian Cancer Society (SIC) in Sesto San Giovanni, Milano (November 23rd-24th, 2009) during the session of “Dietary Supplements and Nutraceuticals in the Management of Cancer”.
- Henry Ford Hospital study shows link between vitamin D, skin cancer
A Henry Ford Hospital study has shown a link between Vitamin D levels and basal cell carcinoma, a finding that could lead researchers to better understand the development of the most common form of skin cancer.
- Henry Ford Hospital study shows link between vitamin D, skin cancer
A Henry Ford Hospital study has shown a link between Vitamin D levels and basal cell carcinoma, a finding that could lead researchers to better understand the development of the most common form of skin cancer.
- Henry Ford Hospital study shows link between vitamin D, skin cancer
A Henry Ford Hospital study has shown a link between Vitamin D levels and basal cell carcinoma, a finding that could lead researchers to better understand the development of the most common form of skin cancer.
- Henry Ford Hospital study shows link between vitamin D, skin cancer
A Henry Ford Hospital study has shown a link between Vitamin D levels and basal cell carcinoma, a finding that could lead researchers to better understand the development of the most common form of skin cancer.
- Henry Ford Hospital study shows link between vitamin D, skin cancer
A Henry Ford Hospital study has shown a link between Vitamin D levels and basal cell carcinoma, a finding that could lead researchers to better understand the development of the most common form of skin cancer.
- Henry Ford Hospital study shows link between vitamin D, skin cancer
A Henry Ford Hospital study has shown a link between Vitamin D levels and basal cell carcinoma, a finding that could lead researchers to better understand the development of the most common form of skin cancer.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- Peer-Reviewed Published Study Demonstrates Safety of UC-II®
A recent study published in Toxicology Mechanisms and Methods demonstrates that UC-II®, InterHealth Nutraceuticals’ 40 mg, once-a-day, joint-health ingredient, is safe.
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
BioVittoria Announces the First Customer Beverage To Be Naturally Sweetened With Fruit-Sweetness™ Clorie-Free Fruit Concentrate
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- Jarrow Formulas® YouTube Channel Approaches 1 Million Views as Olympian-Endorsed Product Video Goes Viral
The overwhelming popularity of the 26-second Olympian-endorsed product video, featuring short-track speed skater Katherine Reutter, reaps 1 million views for the Jarrow Formulas® YouTube Channel.
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- ISO14001 certification granted to Indena
Indena has been granted the ISO14001 certification for its main production site of Settala (Milan).
- New Company for “Change-The-World” Entrepreneurs™ Launches
- GMP Labs Expands Liquid Nutraceutical Capabilities
- What Parents Should Know About Kids and Supplements
- What Parents Should Know About Kids and Supplements
- Oats Beat Back Cholesterol
- Oats Beat Back Cholesterol
- Seniors: Pump Up for Strong Bones and Heart
- Seniors: Pump Up for Strong Bones and Heart
|
Numerous phytochemicals have been reported to interfere with specific stages of the carcinogenic process [1]. Some of these phytochemicals like curcumin induce apoptosis and cell cycle arrest in prostate cancer cells [2] while green tea has been shown to inhibit prostate cancer development and distant site metastasis in TRAMP mice [3]. Similarly, resveratrol has also been associated with inhibition of various cancers. Based on the premise that a combination of phytochemicals in the dietary form is likely to be as effective as individual molecules in reducing cancer cell proliferation, we investigated the in vitro and in vivo effects of a dietary cocktail, Blueberry Punch (BBP*; Dr Red Nutraceuticals Pty Ltd, Queensland, Australia), that incorporates the above mentioned phytoconstituents, on prostate cancer growth.
Prostate cancer cell (PC3, LNCaP) growth showed a dose-dependent reduction compared with untreated cells after 72 hours of exposure to increasing concentrations (0.08% - 5%) of BBP. This reduction in cell growth was due to decreased DNA synthesis as evaluated by 3H-thymdine incorporation. Non-cancer prostate epithelial cells (PrEC) exposed to same concentrations of BBP demonstrated resistance in terms of cell growth reduction. Exposing cancer cells to varying concentrations of mannitol indicated that the observed effects on cancer cell growth were independent of osmolarity. Immunostaining of BBP treated cells indicated reduced phospho Akt, cyclooxygenase and phospho-cytosolic phospholipase A2 levels. For in vivo studies, immunodeficient nude Balb/C mice were inoculated with 5x105 prostate cancer cells (PC-3) and treatment commenced when the tumors reached between 150-200mm3. Mice (n = 8) were administered BBP (10%) in drinking water for two weeks and tumor size and body weights monitored twice per week. At two weeks of treatment the tumor size showed a significant decrease (p=0.004, by two-way ANOVA with repeated measures) compared with mice (n = 8) that were administered regular tap water. Our data provide evidence for in vitro and in vivo suppressive effects of BBP on prostate cancer cell growth. Further studies to determine the mechanistic pathways involved in the inhibition of cancer cell growth are in progress.
* BBP Ingredients – Fruit juice concentrate (blueberry, red grapes, raspberry and elderberry), grape seed and skin extract, citrus skin extracts, green tea extract, olive leaf/olive pulp extracts, tarragon, turmeric and ginger.
1. Surh YJ (2003) Nat Rev Cancer, 3; 768-780
2. Khor et al (2006) Cancer Res, 66; 613-21
3. Gupta (2001) PNAS, 98; 10350-10355 |